Following people with bleeding in the brain to track their recovery
Follows adults with spontaneous bleeding in the brain to study recovery and thinking.
Plain-language title generated from the registry record
Registry title: Prospective Cohort of Patients With Intracerebral Hemorrhage
Key facts
- Where
- Fuzhou, Liaocheng, Quanzhou, Xiamen, and Zhangzhou, ChinaSee the 6 sites
Where in China
- First Affiliated Hospital of Fujian Medical UniversityFuzhou, ChinaTaking people
- Liaocheng People's HospitalLiaocheng, ChinaTaking people
- Anxi County HospitalQuanzhou, ChinaTaking people
- Jinjiang Municipal HospitalQuanzhou, ChinaTaking people
- The Second Affiliated lospital of Xiamen Medical CollegeXiamen, ChinaTaking people
- Zhangzhou Municipal HospitalZhangzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- De-zhi Kang
- Trial code
- NCT06670456
- Record updated
- 1 November 2024
- Original description
The investigators designed a multicentral, observational, prospective cohort study to provide cortical data for risk stratification and biomarkers on early outcomes, complications, long-term neurological function, and cognitive status of spontaneous intracerebral hemorrhage patients.Read full original descriptionShow less
Multicentral Observational Prospective Cohort of Patients With Spontaneous Intracerebral Hemorrhage
The investigators designed a multicentral, observational, prospective cohort study to provide cortical data for risk stratification and biomarkers on early outcomes, complications, long-term neurological function, and cognitive status of spontaneous intracerebral hemorrhage patients.
Inclusion: Diagnosed with spontaneous intracerebral hemorrhage (ICH) through skull radiologic scans (CT or MRI); Underwent no surgical intervention.
Exclusion: Secondary intracerebral hemorrhage (with leading cause, e.g., Moyamoya disease, arteriovenous malformation, intracranial aneurysm, tumor, brain trauma); Pre-stroke life expectancy \< 1 year for severe comorbidities (e.g., Progressive malignant tumor, severe chronic heart failure [NYHA: III-IV], severe chronic obstructive pulmonary disease [III-IV], chronic kidney disease requiring hemodialysis); Severe dependency or incorporation to interview (e.g., pre-stroke mRS\>3, severe dementia, intractable mental disease); Unsuitable for inclusion in the study in the opinion of the investigator.